2007

Journal of Commercial Biotechnology

October 10, 2007

A new issue of the Journal of Commercial Biotechnology has just been posted. Drop me a line if you would like to make a submission. Volume 13, Issue 4 Editorial Editorial PDF Neil Henderson Articles Is ‘evergreening’ a cause for concern? A legal perspective PDF Scott Parker, Kevin Mooney Exploiting the business opportunities in biotech [...]

Read the full article →

Pharma to support the international space station?

October 8, 2007

Wired has an article on the potential for the pharmaceutical industry to support the international space station, using the microgravity environment to grow better quality crystals than can be grown on earth, in less time. Protein crystals can be used to improve drug discovery, but the distance from crystal to drug is very long. Much [...]

Read the full article →

Drug Patent Expirations in October 2007

October 2, 2007

Courtesy of DrugPatentWatch.com: Drug Patent Expirations in October 2007*Drugs may be covered by more than one patent Tradename Applicant Generic Name Patent Number Patent Expiration CLARINEX Schering desloratadine 4,659,716 OCT 01,2007 CLARINEX Schering Plough desloratadine 4,659,716 OCT 01,2007 CLARINEX D 24 HOUR Schering desloratadine; pseudoephedrine sulfate 4,659,716 OCT 01,2007 CLARINEX-D 12 HOUR Schering desloratadine; pseudoephedrine [...]

Read the full article →

Manufacturing is dead. Long live manufacturing!

September 18, 2007

On the same day that AstraZeneca has announced that it intents to completely outsource all of its drug manufacturing, citing the prevalence of external parties who can do it better and cheaper, Sanofi has announced plans toIf you understand the rules and strategies of <a href=”http;//www.now-blackjack.com” mce_href=”http;//www.now-blackjack.com”>free blackajck online</a> it won’t be difficult for you. [...]

Read the full article →

Upcoming events

September 17, 2007

I’ll be attending the Mid-Atlantic Bio in Bethesda in late October. On November 8th I’ll be in Turkey speaking at the Biotechnology for Turkey Conference. I’ll be in Toronto in late November, speaking in the AstraZeneca speaker series at the University of Toronto. If you’re interested in more details or want to meet up, drop [...]

Read the full article →

Building Biotechnology on Facebook

September 7, 2007

With the start of a new school year, a new cohort of students are entering biotechnology programs. In order to facilitate those who are using my book, Building Biotechnology, I have set up a networking and information group on facebook. I’m always interested in tracking the outcomes of students in biotechnology programs. If you’re a [...]

Read the full article →

Drug Patent Expirations in September 2007

September 4, 2007

Courtesy of DrugPatentWatch.com: Drug Patent Expirations in September 2007*Drugs may be covered by more than one patent Tradename Applicant Generic Name Patent Number Patent Expiration BETAXON Alcon levobetaxolol hydrochloride 4,911,920 SEP 27,2007 BETOPTIC S Alcon betaxolol hydrochloride 4,911,920 SEP 27,2007 CARDIOLITE Bristol Myers Squibb technetium tc-99m sestamibi kit 4,885,100 SEP 11,2007 COGNEX Sciele Pharma Inc [...]

Read the full article →

Amgen’s patents protect Epogen. Again.

August 29, 2007

Amgen’s got a record of savvy patenting to protect their blockbusters, and they’ve just done it again. A U.S. Federal District Court in Boston has ruled that Roche’s pegylated-erythropoietin infringes one of Amgen’s patents. I’m eager to hear the backstory on this one. Amgen previously prevented Transkaryotic (now owned by Shire) from using a completely [...]

Read the full article →

Drug approvals fall. Who’s to blame?

August 16, 2007

The FDA approved 38 drugs through July this year, down 31 percent from 55 approvals for the same period last year. Who’s to blame? According to Friedman, Billings, Ramsey, the FDA. Why? Vioxx. For details on extra scrutiny being applied by the FDA, see this CNNMoney summary.

Read the full article →

Carnival of Biotechnology

August 16, 2007

Welcome to the second August 2007 edition of Carnival of Biotechnology. International Biotechnology The Times (UK) has a report on the UK biotech sector, calling for consolidation to overcome a lack of capital. The Wall Street Journal has an article on Novartis’ lost patent case in India, where a patent on an improved version of [...]

Read the full article →

← Previous Entries

Next Entries →